NCT03741231
- Conditions
- 18F-FDG, Immunotherapy, Melanoma, +13 more
- Locations
-
- CHRU de Brest Brest, France
- CH de LANDERNEAU Landerneau, France
- Centre Hospitalier de Morlaix Morlaix, France
Clinical trial condition
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
NCT03741231
NCT02251314
NCT03155217
NCT02457273
NCT02117362
NCT02122861
NCT00223899
NCT01100528
NCT00470015
NCT02668887